Ergocalciferol and Emgality drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Emgality (galcanezumab-gnlm). Common drug interactions include pain among females and blood iron increased among males.
The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Emgality. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
What is Emgality?
Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.
18 people who take Ergocalciferol and Emgality together, and have interactions are studied.

What are the common drug interactions of Ergocalciferol and Emgality, by gender? *:
female:
- Pain
- Hypertension (high blood pressure)
- Asthma
- Abdominal pain
- Abdominal pain upper
- Blood creatinine increased
- Drug ineffective
- Emotional distress
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Heart rate increased
male:
- Blood iron increased
- Dizziness
- Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
- Sluggishness (lacking alertness)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Drug ineffective
- Fall
- Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
- Migraine (headache)
- Nasopharyngitis (inflammation of the nasopharynx)
What are the common drug interactions of Ergocalciferol and Emgality, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anaemia (lack of blood)
40-49:
- Pain
- Abdominal pain
- Abdominal pain upper
- Blood creatinine increased
- Emotional distress
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Renal impairment (severely reduced kidney function)
- Back pain
- Drug ineffective
- Dyspnoea (difficult or laboured respiration)
50-59:
- Asthma
- Chronic kidney disease
- Cough
- Drug ineffective
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hospitalisation
- Human rhinovirus test positive
- Nasopharyngitis (inflammation of the nasopharynx)
- Restless legs syndrome (a powerful urge to move your legs)
60+:
- Alopecia (absence of hair from areas of the body)
- Arrhythmia (irregular heartbeat)
- Pyrexia (fever)
- Sleep disorder due to a general medical condition
- Blood calcium decreased
- Chills (felling of cold)
- Hypertension (high blood pressure)
- Influenza
- Migraine (headache)
- Muscle spasms (muscle contraction)
What are the existing conditions these people have? *
- Drowsiness: 6 people, 33.33%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 27.78%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 27.78%
- Migraine (headache): 5 people, 27.78%
- Depression: 3 people, 16.67%
- High Blood Pressure: 2 people, 11.11%
- Hiv Infection: 2 people, 11.11%
- Asthma: 2 people, 11.11%
- Bacterial Infection: 2 people, 11.11%
- Blood Potassium Decreased: 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Emgality?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ergocalciferol (32,652 reports)
- Emgality (24,702 reports)
Browse all drug interactions of Ergocalciferol and Emgality:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Emgality:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emgality and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and galcanezumab-gnlm (the active ingredients of Ergocalciferol and Emgality, respectively), and Ergocalciferol and Emgality (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cymbalta cause Social Avoidant Behavior? - 6 seconds ago
- Sedation and Back Pain - 11 seconds ago
- Drug interactions of Trisenox and Diflucan - 29 seconds ago
- Could Aleve cause Scratch? - 42 seconds ago
- Drug interactions of Ramipril and Zejula - 52 seconds ago
- Drug interactions of Kazano and Pantoprazole - 52 seconds ago
- Could Cyclobenzaprine Hydrochloride cause Lump In The Abdomen? - 55 seconds ago
- Could Nifedipine cause Paranoia? - 58 seconds ago
- Insomnia and Bradykinesia - a minute ago
- Could Plavix cause Muscle Rigidity? - a minute ago